Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
359 Results Found
Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.
CMS releases initial guidance on negotiating certain Medicare drug prices
The Centers for Medicare & Medicaid Services this week released for comment initial guidance implementing a program for Medicare to negotiate prices with drug makers for certain high-cost, single-source drug and biological products beginning in 2026 under the Inflation Reduction Act.
CMS to Reduce Medicare Coinsurance for 27 Part B Drugs, Starting April 1
The Centers for Medicare and Medicaid Services (CMS) March 15 announced 27 prescription drugs for which it will lower Part B beneficiary coinsurance, beginning April 1 through June 30, 2023, as required by the Inflation Reduction Act (IRA).
Drugs with Adjusted Coinsurance Amounts for the Quarter April 1-June 30, 2023
The Centers for Medicare and Medicaid Services (CMS) March 15 announced 27 prescription drugs for which it will lower Part B beneficiary coinsurance, beginning April 1 through June 30, 2023, as required by the Inflation Reduction Act (IRA). This is a table of those drugs.
Inflation rebates to reduce Medicare payment for 27 Part B drugs
This April through June under the Inflation Reduction Act, Medicare will reduce the coinsurance amount for 27 Part B prescription drugs from 20% to somewhere between 10% and 19.9%, depending on the drug, the Centers for Medicare & Medicaid Services announced today.
Drug Prices
Hospitals bear a heavy financial burden when the cost of drugs increases. They are not only major purchasers of drugs, but patients often end up in the hospital when they cannot afford to take their medications as prescribed. To that end, the American Hospital Association is proud to be a member of the Campaign for Sustainable Rx Pricing -– a diverse coalition of doctors, hospitals, pharmacists, employers, health plans, seniors, patients, consumers and others coming together to find common ground and solutions.
3 Ways Pharma Could Jolt Health Care in 2023
The market for biosimilar drugs to treat cancer, inflammatory diseases, diabetes and more will continue to expand, ideally resulting in lower prices as more pharmaceutical patents expire and competitors enter the market.
AHA shares Part B drug payment, telehealth recommendations with MedPAC
Medicare should continue to pay average sales price plus 6% for most separately payable Part B drugs, but cap ASP inflation, AHA told the Medicare Payment Advisory Commission in comments submitted today.
CMS to test new models to lower drug costs
The CMS Innovation Center will test three new models to see whether they lower high drug costs, the Centers for Medicare & Medicaid Services announced yesterday.
The Latest Shakeup in the Prescription Drug Market: $5 Generics via Amazon Prime
Amazon Pharmacy steadily has been capturing business from large and small retail pharmacies, but its latest venture — RxPass —significantly could expand its customer base.